Literature DB >> 30122219

Detection of AR-V7 transcript with RNA in situ hybridization in human salivary duct cancer.

Hyunseok Kang1, Emmanuel S Antonarakis2, Jun Luo3, Qizhi Zheng4, Lisa Rooper5, Angelo M De Marzo6, William H Westra7, Tamara L Lotan6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30122219     DOI： 10.1016/j.oraloncology.2018.06.026

Source DB:  PubMed          Journal:  Oral Oncol        ISSN： 1368-8375            Impact factor:   5.337


× No keyword cloud information.
  3 in total

1.  Phase 1 study of the HSP90 inhibitor onalespib in combination with AT7519, a pan-CDK inhibitor, in patients with advanced solid tumors.

Authors:  Khanh T Do; Geraldine O'Sullivan Coyne; John L Hays; Jeffrey G Supko; Stephen V Liu; Kristin Beebe; Len Neckers; Jane B Trepel; Min-Jung Lee; Tomoko Smyth; Courtney Gannon; Jennifer Hedglin; Alona Muzikansky; Susana Campos; John Lyons; Percy Ivy; James H Doroshow; Alice P Chen; Geoffrey I Shapiro
Journal:  Cancer Chemother Pharmacol       Date:  2020-10-23       Impact factor: 3.333

2.  Guidelines for the Optimization and Validation of In Situ Hybridization.

Authors:  Julia Jones; William J Howat
Journal:  Methods Mol Biol       Date:  2020

3.  Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling.

Authors:  Stacey M Gargano; Wijendra Senarathne; Rebecca Feldman; Elena Florento; Phillip Stafford; Jeffrey Swensen; Semir Vranic; Zoran Gatalica
Journal:  Cancer Med       Date:  2019-10-14       Impact factor: 4.452
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.